Neurovascular devices refer to medical instrumentation designed for treatments that deal with blood vessels conditions in the human brain.
The neurovascular devices market size in 2021 was US$ 3.22 billion and is expected to reach US$ 5.79 billion by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 6.2% in 2023–2031.
https://www.theinsightpartners.com/assets/rd-new-images/by_geography/neurovascular-devices-market-global-geography.webp
Regional Analysis
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Critical in managing these neurovascular diseases, the treatments include aneurysms, arteriovenous malformations, or ischemic strokes.
The neurovascular devices market size in 2021 was US$ 3.22 billion and is expected to reach US$ 5.79 billion by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 6.2% in 2023–2031.
https://www.theinsightpartners.com/assets/rd-new-images/by_geography/neurovascular-devices-market-global-geography.webp
Regional Analysis
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Critical in managing these neurovascular diseases, the treatments include aneurysms, arteriovenous malformations, or ischemic strokes.
Neurovascular devices refer to medical instrumentation designed for treatments that deal with blood vessels conditions in the human brain.
The neurovascular devices market size in 2021 was US$ 3.22 billion and is expected to reach US$ 5.79 billion by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 6.2% in 2023–2031.
https://www.theinsightpartners.com/assets/rd-new-images/by_geography/neurovascular-devices-market-global-geography.webp
Regional Analysis
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Critical in managing these neurovascular diseases, the treatments include aneurysms, arteriovenous malformations, or ischemic strokes.
0 Comments
0 Shares
114 Views
0 Reviews